Menu

CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: October-30-14
Credit Expiration Date: October-30-15

Faculty

Chris Garvey FNP, MSN, MPA, FAACVPR
Manager
Seton Pulmonary and Cardiac Rehabilitation
Daly City, CA

Credit Hours

1.0 AMA PRA Category 1 Credit

Medium

Online Presentation

Program Description

Chronic obstructive pulmonary disease (COPD) is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise tolerance, chronic cough with or without sputum production, wheezing, and respiratory failure or right heart failure. In the United States, COPD affects more than 5% of the adult population and is the third leading cause of death. Advances in medical therapies and better disease management approaches have increased the recognition that COPD is preventable and treatable. Yet, COPD remains both underdiagnosed and undertreated in primary care settings.

Program Developer/Facilitator


.

Target Audience

This activity is intended for NPs and PAs involved in the diagnosis and management of patients with COPD.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Identify patients for whom a diagnosis of COPD should be considered.
  2. Explain the process for completing a combined assessment of COPD that includes spirometry to evaluate symptoms, airflow limitation, and the risk of exacerbations.
  3. Explain why maintenance therapy requires the inclusion of long-acting inhalation therapies.
  4. Describe the rationale for prescribing long-acting agents, including a long-acting beta agonist or a long-acting anticholinergic.

Disclosures

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Chris Garvey, FNP, MSN, MPA, FAACVPR, discloses that she has served as a consultant for Boehringer Ingelheim.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN: Nothing to disclose
Amanda Glazar, PhD: Nothing to disclose
Andrea Funk: Nothing to disclose
Gena Dolson: Nothing to disclose


Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and MCM Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MCM Education. Global is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com.

This activity is jointly provided by Global Education Group and MCM Education.

Commercial Support Statements

This activity is supported by independent education grants from Boehringer Ingelheim Pharmaceuticals, Inc., and Novartis Pharmaceuticals Corporation.

Certificate Fee

$0.00

Disclaimer

©2014, MCM Education. All rights reserved. This activity is designed to provide the health care professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. None of the content may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this interactive case study are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Global Education Group, Boehringer Ingelheim Pharmaceuticals, Inc. or Novartis Pharmaceuticals Corporation. Any medications or other diagnostic or treatment procedures presented by the program faculty should not be utilized by clinicians without evaluation of their patients’ conditions and possible contraindications or risks or without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu
EDITOR'S PICKS